Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Chang (2003)
Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a closed conformation.Journal of molecular biology, 330 2
V. Ling, N. Kartner, T. Sudo, L. Siminovitch, J. Riordan (1983)
Multidrug-resistance phenotype in Chinese hamster ovary cells.Cancer treatment reports, 67 10
M. Rosenberg, R. Callaghan, S. Modok, C. Higgins, R. Ford (2005)
Three-dimensional Structure of P-glycoproteinJournal of Biological Chemistry, 280
E. Crowley, M. O’Mara, I. Kerr, R. Callaghan (2010)
Transmembrane helix 12 plays a pivotal role in coupling energy provision and drug binding in ABCB1The FEBS Journal, 277
T. Loo, D. Clarke (2001)
Defining the Drug-binding Site in the Human Multidrug Resistance P-glycoprotein Using a Methanethiosulfonate Analog of Verapamil, MTS-verapamil*The Journal of Biological Chemistry, 276
J. Taylor, D. Ferry, C. Higgins, R. Callaghan (1999)
The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similarBritish Journal of Cancer, 81
Nazli Maki, P. Hafkemeyer, S. Dey (2003)
Allosteric Modulation of Human P-glycoproteinThe Journal of Biological Chemistry, 278
Qin Qu, F. Sharom (2001)
FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated.Biochemistry, 40 5
S. Frillingos, M. Sahin-Tóth, Jianhua Wu, H. Kaback (1998)
Cys‐scanning mutagenesis: a novel approach to structure—function relationships in polytopic membrane proteinsThe FASEB Journal, 12
G. Ecker, E. Csaszar, S. Kopp, B. Plagens, W. Holzer, Wolfgang Ernst, P. Chiba (2002)
Identification of ligand-binding regions of P-glycoprotein by activated-pharmacophore photoaffinity labeling and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry.Molecular pharmacology, 61 3
J. Wonderen, R. McMahon, M. O’Mara, C. McDevitt, A. Thomson, I. Kerr, F. MacMillan, R. Callaghan (2014)
The central cavity of ABCB1 undergoes alternating access during ATP hydrolysisThe FEBS Journal, 281
Qin Qu, F. Sharom (2002)
Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet.Biochemistry, 41 14
Catherine Martin, Georgina Berridge, Christopher Higgins, Prakash Mistry, Peter Charlton, Richard Callaghan (2000)
Communication between multiple drug binding sites on P-glycoprotein.Molecular pharmacology, 58 3
Adam Shapiro, Victor Ling (1998)
Transport of LDS-751 from the cytoplasmic leaflet of the plasma membrane by the rhodamine-123-selective site of P-glycoprotein.European journal of biochemistry, 254 1
A. Safa (1988)
Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil.Proceedings of the National Academy of Sciences of the United States of America, 85 19
M. Gottesman, S. Ambudkar, D. Xia (2009)
Structure of a multidrug transporterNature Biotechnology, 27
T. Loo, D. Clarke (2002)
Location of the Rhodamine-binding Site in the Human Multidrug Resistance P-glycoprotein*The Journal of Biological Chemistry, 277
R. Dawson, K. Locher (2007)
Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP‐PNPFEBS Letters, 581
Stéphane Vandevuer, F. Bambeke, P. Tulkens, M. Prévost (2006)
Predicting the three‐dimensional structure of human P‐glycoprotein in absence of ATP by computational techniques embodying crosslinking data: Insight into the mechanism of ligand migration and binding sitesProteins: Structure, 63
F. Sharom (1997)
The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?The Journal of Membrane Biology, 160
A. Seelig (1998)
A general pattern for substrate recognition by P-glycoprotein.European journal of biochemistry, 251 1-2
A. Ward, P. Szewczyk, Vinciane Grimard, Chang-wook Lee, Lorena Martínez, R. Doshi, Alexandra Caya, Mark Villaluz, E. Pardon, Cristina Cregger, D. Swartz, P. Falson, I. Urbatsch, C. Govaerts, J. Steyaert, G. Chang (2013)
Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domainProceedings of the National Academy of Sciences, 110
T. Loo, M. Bartlett, D. Clarke (2006)
Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket.The Biochemical journal, 396 3
T. Loo, M. Bartlett, D. Clarke (2003)
Substrate-induced Conformational Changes in the Transmembrane Segments of Human P-glycoproteinThe Journal of Biological Chemistry, 278
Catherine Martin, G. Berridge, P. Mistry, Christopher Higgins, P. Charlton, R. Callaghan (1999)
The molecular interaction of the high affinity reversal agent XR9576 with P‐glycoproteinBritish Journal of Pharmacology, 128
T. Loo, D. Clarke (1995)
Rapid Purification of Human P-glycoprotein Mutants Expressed Transiently in HEK 293 Cells by Nickel-Chelate Chromatography and Characterization of their Drug-stimulated ATPase Activities (*)The Journal of Biological Chemistry, 270
M. O’Mara, D. Tieleman (2007)
P‐glycoprotein models of the apo and ATP‐bound states based on homology with Sav1866 and MalKFEBS Letters, 581
R. Dawson, K. Locher (2006)
Structure of a bacterial multidrug ABC transporterNature, 443
A. Garrigues, N. Loiseau, M. Delaforge, J. Ferté, M. Garrigos, F. André, S. Orlowski (2002)
Characterization of two pharmacophores on the multidrug transporter P-glycoprotein.Molecular pharmacology, 62 6
T. Stouch, O. Gudmundsson (2002)
Progress in understanding the structure-activity relationships of P-glycoprotein.Advanced drug delivery reviews, 54 3
T. Loo, D. Clarke (2000)
Identification of Residues within the Drug-binding Domain of the Human Multidrug Resistance P-glycoprotein by Cysteine-scanning Mutagenesis and Reaction with Dibromobimane*The Journal of Biological Chemistry, 275
T. Loo, D. Clarke (1997)
Identification of Residues in the Drug-binding Site of Human P-glycoprotein Using a Thiol-reactive Substrate*The Journal of Biological Chemistry, 272
D. Ferry, P.Joy Malkhandi, M. Russell, D. Kerr (1995)
Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine.Biochemical pharmacology, 49 12
V. Ling, L. Thompson (1974)
Reduced permeability in CHO cells as a mechanism of resistance to colchicineJournal of Cellular Physiology, 83
David Ferry, Michael Russell, Michael Cullen (1992)
P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site.Biochemical and biophysical research communications, 188 1
F. Montanari, G. Ecker (2015)
Prediction of drug–ABC-transporter interaction — Recent advances and future challenges☆Advanced drug delivery reviews, 86
T. Loo, M. Bartlett, D. Clarke (2003)
Simultaneous Binding of Two Different Drugs in the Binding Pocket of the Human Multidrug Resistance P-glycoprotein*Journal of Biological Chemistry, 278
L. Homolya, Z. Holló, U. Germann, I. Pastan, M. Gottesman, B. Sarkadi (1993)
Fluorescent cellular indicators are extruded by the multidrug resistance protein.The Journal of biological chemistry, 268 29
T. Loo, M. Bartlett, D. Clarke (2003)
Permanent Activation of the Human P-glycoprotein by Covalent Modification of a Residue in the Drug-binding Site*Journal of Biological Chemistry, 278
Adam Shapiro, Victor Ling (1997)
Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.European journal of biochemistry, 250 1
Catherine Martin, Christopher Higgins, Richard Callaghan (2001)
The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein.Biochemistry, 40 51
T. Loo, M. Bartlett, D. Clarke (2006)
Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket.The Biochemical journal, 399 2
D. Ferry, K. Kämpf, A. Goll, H. Glossmann (1985)
Subunit composition of skeletal muscle transverse tubule calcium channels evaluated with the 1,4‐dihydropyridine photoaffinity probe, [3H]azidopine.The EMBO Journal, 4
C. Higgins (1992)
ABC transporters: from microorganisms to man.Annual review of cell biology, 8
A. Rothnie, J. Storm, Jeff Campbell, K. Linton, I. Kerr, R. Callaghan (2004)
The Topography of Transmembrane Segment Six Is Altered during the Catalytic Cycle of P-glycoprotein*Journal of Biological Chemistry, 279
E. Crowley, R. Callaghan (2010)
Multidrug efflux pumps: drug binding – gates or cavity?The FEBS Journal, 277
A. Safa, N. Mehta, M. Agresti (1989)
Photoaffinity labeling of P-glycoprotein in multidrug resistant cells with photoactive analogs of colchicine.Biochemical and biophysical research communications, 162 3
Bärbel Isenberg, Hubert Thole, Burkhard Tümmler, A. Demmer (2001)
Identification and localization of three photobinding sites of iodoarylazidoprazosin in hamster P-glycoprotein.European journal of biochemistry, 268 9
John Riordan, Victor Ling (1985)
Genetic and biochemical characterization of multidrug resistance.Pharmacology & therapeutics, 28 1
I. Pajeva, M. Wiese (2002)
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).Journal of medicinal chemistry, 45 26
M. Rosenberg, A. Kamis, R. Callaghan, C. Higgins, R. Ford (2003)
Three-dimensional Structures of the Mammalian Multidrug Resistance P-glycoprotein Demonstrate Major Conformational Changes in the Transmembrane Domains upon Nucleotide Binding*The Journal of Biological Chemistry, 278
T. Kenakin (1987)
A Pharmacologic Analysis of Drug-Receptor Interaction
R. Callaghan, G. Berridge, D. Ferry, C. Higgins (1997)
The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface.Biochimica et biophysica acta, 1328 2
L. Greenberger, C. Yang, E. Gindin, S. Horwitz (1990)
Photoaffinity probes for the alpha 1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein.The Journal of biological chemistry, 265 8
P. Ghosh, Karobi Moitra, Nazli Maki, S. Dey (2006)
Allosteric modulation of the human P-glycoprotein involves conformational changes mimicking catalytic transition intermediates.Archives of biochemistry and biophysics, 450 1
Paul Smith, N. Karpowich, Linda Millen, Jonathan Moody, J. Rosen, P. Thomas, J. Hunt (2002)
ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer.Molecular cell, 10 1
Mikihiko Naito, Keisuke Yusa, Takashi Tsuruo (1989)
Steroid hormones inhibit binding of Vinca alkaloid to multidrug resistance related P-glycoprotein.Biochemical and biophysical research communications, 158 3
A. Pawagi, J. Wang, M. Silverman, R. Reithmeier, C. Deber (1994)
Transmembrane aromatic amino acid distribution in P-glycoprotein. A functional role in broad substrate specificity.Journal of molecular biology, 235 2
A. Safa (2004)
Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.Current medicinal chemistry. Anti-cancer agents, 4 1
T. Kenakin (2004)
Principles: receptor theory in pharmacology.Trends in pharmacological sciences, 25 4
A. Shapiro, Kelly Fox, P. Lam, V. Ling (2001)
Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site.European journal of biochemistry, 259 3
Q. Wu, P. Bounaud, S. Kuduk, C. Yang, I. Ojima, S. Horwitz, G. Orr (1998)
Identification of the domains of photoincorporation of the 3'- and 7-benzophenone analogues of taxol in the carboxyl-terminal half of murine mdr1b P-glycoprotein.Biochemistry, 37 32
A. Safa (1999)
Photoaffinity analogs for multidrug resistance-related transporters and their use in identifying chemosensitizers.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2 6
P. Chiba, S. Burghofer, E. Richter, B. Tell, A. Moser, G. Ecker (1995)
Synthesis, pharmacologic activity, and structure-activity relationships of a series of propafenone-related modulators of multidrug resistance.Journal of medicinal chemistry, 38 14
J. Lankelma, E. Spoelstra, H. Dekker, H. Broxterman (1990)
Evidence for daunomycin efflux from multidrug-resistant 2780AD human ovarian carcinoma cells against a concentration gradient.Biochimica et biophysica acta, 1055 3
L. Greenberger (1993)
Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12.The Journal of biological chemistry, 268 15
J. Storm, M. O’Mara, E. Crowley, Jonathan Peall, D. Tieleman, I. Kerr, R. Callaghan (2007)
Residue G346 in transmembrane segment six is involved in inter-domain communication in P-glycoprotein.Biochemistry, 46 35
S. Dey, P. Hafkemeyer, I. Pastan, M. Gottesman (1999)
A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol.Biochemistry, 38 20
Miguel Lugo, F. Sharom (2009)
Interaction of LDS-751 with the drug-binding site of P-glycoprotein: a Trp fluorescence steady-state and lifetime study.Archives of biochemistry and biophysics, 492 1-2
A. Shapiro, V. Ling (1997)
Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein.Biochemical pharmacology, 53 4
M. O’Mara, A. Mark (2014)
Structural Characterization of Two Metastable ATP-Bound States of P-GlycoproteinPLoS ONE, 9
K. Ueda, Y. Taguchi, M. Morishima (1997)
How does P-glycoprotein recognize its substrates?Seminars in cancer biology, 8 3
A. Shapiro, V. Ling (1995)
Reconstitution of Drug Transport by Purified P-glycoprotein (*)The Journal of Biological Chemistry, 270
Xiaoping Zhang, Karen Collins, L. Greenberger (1995)
Functional Evidence That Transmembrane 12 and the Loop between Transmembrane 11 and 12 Form Part of the Drug-binding Domain in P-glycoprotein Encoded by MDR1 (*)The Journal of Biological Chemistry, 270
Thomas Raub (2006)
P-glycoprotein recognition of substrates and circumvention through rational drug design.Molecular pharmaceutics, 3 1
Chang-jie Chen, J. Chin, K. Ueda, D. Clark, I. Pastan, M. Gottesman, I. Roninson (1986)
Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 47
T. Loo, D. Clarke (1999)
Identification of Residues in the Drug-binding Domain of Human P-glycoproteinThe Journal of Biological Chemistry, 274
M. Jin, M. Oldham, Qiu-ju Zhang, Jue Chen (2012)
Crystal structure of the multidrug transporter P-glycoprotein from C. elegansNature, 490
Andrewf Taylor, J. Storm, Loredana Soceneantu, K. Linton, Mark Gabriel, Catherine Martin, James Woodhouse, E. Blott, C. Higgins, R. Callaghan (2001)
Detailed characterization of cysteine‐less P‐glycoprotein reveals subtle pharmacological differences in function from wild‐type proteinBritish Journal of Pharmacology, 134
M. Garrigos, Lluis Mir, Stéphane Orlowski (1997)
Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.European journal of biochemistry, 244 2
C. Higgins, K. Linton (2004)
The ATP switch model for ABC transportersNature Structural &Molecular Biology, 11
N. Subramanian, Karmen Condic-Jurkic, A. Mark, M. O’Mara (2015)
Identification of Possible Binding Sites for Morphine and Nicardipine on the Multidrug Transporter P-Glycoprotein Using Umbrella Sampling TechniquesJournal of chemical information and modeling, 55 6
N. Sonveaux, A. Shapiro, E. Goormaghtigh, V. Ling, J. Ruysschaert (1996)
Secondary and Tertiary Structure Changes of Reconstituted P-glycoproteinThe Journal of Biological Chemistry, 271
Miguel Lugo, F. Sharom (2005)
Interaction of LDS-751 and rhodamine 123 with P-glycoprotein: evidence for simultaneous binding of both drugs.Biochemistry, 44 42
T. Loo, D. Clarke (2005)
Do drug substrates enter the common drug-binding pocket of P-glycoprotein through "gates"?Biochemical and biophysical research communications, 329 2
T. Loo, D. Clarke (1993)
Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein.The Journal of biological chemistry, 268 5
N. Lerner‐Marmarosh, K. Gimi, I. Urbatsch, P. Gros, A. Senior (1999)
Large Scale Purification of Detergent-soluble P-glycoprotein fromPichia pastoris Cells and Characterization of Nucleotide Binding Properties of Wild-type, Walker A, and Walker B Mutant Proteins*The Journal of Biological Chemistry, 274
Yossef Raviv, Harvey Pollard, E. Bruggemann, Ira Pastany, Michael Gottesmanllll (1990)
Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells.The Journal of biological chemistry, 265 7
K. Danø (1973)
Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells.Biochimica et biophysica acta, 323 3
M. Rosenberg, Giles Velarde, R. Ford, Catherine Martin, G. Berridge, I. Kerr, R. Callaghan, Andreas Schmidlin, C. Wooding, K. Linton, C. Higgins (2001)
Repacking of the transmembrane domains of P‐glycoprotein during the transport ATPase cycleThe EMBO Journal, 20
J. Storm, S. Modok, Megan O’Mara, D. Tieleman, Ian Kerr, R. Callaghan (2008)
Cytosolic region of TM6 in P-glycoprotein: topographical analysis and functional perturbation by site directed labeling.Biochemistry, 47 12
J. Gribar, M. Ramachandra, C. Hrycyna, S. Dey, S. Ambudkar (2000)
Functional Characterization of Glycosylation-Deficient Human P-Glycoprotein Using A Vaccinia Virus Expression SystemThe Journal of Membrane Biology, 173
A. Ravna, I. Sylte, Georg Sager, Georg Sager-Georg, No (2007)
Theoretical Biology and Medical Modelling Open Access Molecular Model of the Outward Facing State of the Human P-glycoprotein (abcb1), and Comparison to a Model of the Human Mrp5 (abcc5)
Karin Pleban, S. Kopp, E. Csaszar, Michael Peer, T. Hrebicek, A. Rizzi, G. Ecker, P. Chiba (2005)
P-Glycoprotein Substrate Binding Domains Are Located at the Transmembrane Domain/Transmembrane Domain Interfaces: A Combined Photoaffinity Labeling-Protein Homology Modeling ApproachMolecular Pharmacology, 67
Jingzhi Li, K. Jaimes, S. Aller (2013)
Refined structures of mouse P-glycoproteinProtein Science : A Publication of the Protein Society, 23
R. Liu, F. Sharom (1996)
Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.Biochemistry, 35 36
E. Bruggemann, U. Germann, Michael Gottesman, I. Pastan (1989)
Two different regions of P-glycoprotein [corrected] are photoaffinity-labeled by azidopine.The Journal of biological chemistry, 264 26
M. Demel, R. Schwaha, Oliver Krämer, Peter Ettmayer, E. Haaksma, G. Ecker (2008)
In silico prediction of substrate properties for ABC-multidrug transportersExpert Opinion on Drug Metabolism & Toxicology, 4
S. Orlowski, M. Garrigos (1999)
Multiple recognition of various amphiphilic molecules by the multidrug resistance P-glycoprotein: molecular mechanisms and pharmacological consequences coming from functional interactions between various drugs.Anticancer research, 19 4B
M. Rosenberg, R. Callaghan, R. Ford, C. Higgins (1997)
Structure of the Multidrug Resistance P-glycoprotein to 2.5 nm Resolution Determined by Electron Microscopy and Image Analysis*The Journal of Biological Chemistry, 272
P. Hafkemeyer, S. Dey, S. Ambudkar, C. Hrycyna, I. Pastan, M. Gottesman (1998)
Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.Biochemistry, 37 46
Catherine Martin, G. Berridge, C. Higgins, R. Callaghan (1997)
The multi‐drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P‐glycoprotein by an allosteric interactionBritish Journal of Pharmacology, 122
S. Dey, M. Ramachandra, I. Pastan, M. Gottesman, S. Ambudkar (1997)
Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.Proceedings of the National Academy of Sciences of the United States of America, 94 20
S. Lazareno, N. Birdsall (1993)
Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng‐Prusoíf equationsBritish Journal of Pharmacology, 109
Lorena Martínez, O. Arnaud, E. Hénin, Houchao Tao, V. Chaptal, R. Doshi, T. Andrieu, S. Dussurgey, M. Tod, A. Pietro, Qinghai Zhang, G. Chang, P. Falson (2014)
Understanding polyspecificity within the substrate‐binding cavity of the human multidrug resistance P‐glycoproteinThe FEBS Journal, 281
C. Pascaud, M. Garrigos, S. Orlowski (1998)
Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.The Biochemical journal, 333 ( Pt 2)
S. Aller, Jodie Yu, A. Ward, Yue Weng, S. Chittaboina, R. Zhuo, P. Harrell, Yenphuong Trinh, Qinghai Zhang, I. Urbatsch, G. Chang (2009)
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug BindingScience, 323
Thomas Litman, Thomas Zeuthen, T. Skovsgaard, Wilfred Stein (1997)
Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity.Biochimica et biophysica acta, 1361 2
R. Liu, A. Siemiarczuk, F. Sharom (2000)
Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides.Biochemistry, 39 48
William Beck, M. Cirtain, Constance Glover, R. Felsted, A. Safa (1988)
Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.Biochemical and biophysical research communications, 153 3
Kazumitsu UedaS, Noboru Okamuraj, Midori Hiraij, Yusuke Tanigawaraj, T. Saeki, N. Kioka, T. Komano, Ryohei Horij (1992)
Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.The Journal of biological chemistry, 267 34
N. Sonveaux, C. Vigano, A. Shapiro, V. Ling, J. Ruysschaert (1999)
Ligand-mediated Tertiary Structure Changes of Reconstituted P-glycoproteinThe Journal of Biological Chemistry, 274
G. Ecker, P. Chiba, M. Hitzler, D. Schmid, K. Visser, H. Cordes, J. Csöllei, J. Seydel, K. Schaper (1996)
Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance.Journal of medicinal chemistry, 39 24
Edward Bruggemanntt, Stephen CurriernII, Michael Gottesmanll, I. Pastan (1992)
Characterization of the azidopine and vinblastine binding site of P-glycoprotein.The Journal of biological chemistry, 267 29
T. Loo, D. Clarke (1995)
Membrane Topology of a Cysteine-less Mutant of Human P-glycoprotein (*)The Journal of Biological Chemistry, 270
Hans, V., Westerhow, Herbert Pinedo (2004)
The multidrug resistance reverser verapamil with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate
Nazli Maki, S. Dey (2006)
Biochemical and pharmacological properties of an allosteric modulator site of the human P-glycoprotein (ABCB1).Biochemical pharmacology, 72 2
E. Crowley, M. O’Mara, C. Reynolds, D. Tieleman, J. Storm, I. Kerr, R. Callaghan (2009)
Transmembrane helix 12 modulates progression of the ATP catalytic cycle in ABCB1.Biochemistry, 48 26
R. Liu, F. Sharom (1997)
Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter.Biochemistry, 36 10
[P-glycoprotein (P-gp) was one of the first discovered, and most highly investigated, multidrug efflux pumps. P-gp was discovered in drug-resistant cancer cells and its ability to mediate adenosine triphosphate (ATP)-dependent efflux of drugs can confer resistance to cancer cells. The protein contains two sites for the binding and hydrolysis of ATP to power the active transport process. Drugs are known to bind within the transmembrane domain that comprises 12 membrane spanning α-helices. Biochemical, pharmacological and biophysical investigations continue to strive towards generating a molecular mechanism for drug transport. In addition, X-ray structures are available for the mouse and Caenorhabditis elegans isoforms at resolutions of 3–4 Å. However, one of the central issues related to the transport process remains elusive. A detailed understanding of how the protein is capable of binding its astonishing variety and number of compounds, remains unsolved. The hydrophobic vacuum cleaner and drug flippase models have been generated to describe this enigmatic property and some of their proposals remain intact. The majority of data supports the presence of a large binding domain that contains individual sites for drug interaction. These interaction sites are linked by an intricate allosteric network and binding to the sites is in close communication with the ATP hydrolytic machinery. This review provides a detailed account of our current understanding of how one membrane transporter is able to bind over 300 compounds.]
Published: Dec 17, 2015
Keywords: P-glycoprotein; Multidrug resistance; Cancer chemotherapy; Membrane transport; Drug–protein interaction
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.